Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Methionine synthase reductase A66G polymorphism is not associated with breast cancer susceptibility - a meta-analysis.

Asian Pacific journal of cancer prevention : APJCP - 1 Jan 2014

Hu Shu, Liu Hong-Chao, Xi Shou-Ming

Abstract excerpt

BACKGROUND: Several studies have investigated the association between methionine synthase reductase (MTRR) A66G polymorphism and breast cancer risk, but controversial results were yielded. Therefore, we performed a meta-analysis to provide a more robust estimate of the effect of this polymorphism on susceptibility to breast cancer. MATERIALS AND METHODS: Case-control studies investigating the relationship between...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Ferredoxin-NADP Reductase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Frequency

Share to MTRR gene

Share to Genetic Predisposition to Disease

Share to Genotype

Share to Polymorphism, Single Nucleotide

Source

Identifiers

PMID: 24815481
DOI: 10.7314/apjcp.2014.15.7.3267

Genes

MTRR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Methionine synthase reductase A66G polymorphism is not associated with breast cancer susceptibility - a meta-analysis.PMID 24815481Read ↗

MTRR A66G polymorphism and breast cancer risk: a meta-analysis.Semantic proximity Read ↗

Methionine synthase A2756G polymorphism and breast cancer risk: a meta-analysis involving 18,953 subjects.Semantic proximity Read ↗

Methionine synthase reductase A66G polymorphism contributes to tumor susceptibility: evidence from 35 case-control studies.Semantic proximity Read ↗

Methionine synthase A2756G polymorphism and breast cancer risk: an up-to-date meta-analysis.Semantic proximity Read ↗

Lack of association between MHTFR Glu429Ala polymorphism and breast cancer susceptibility: a systematic review and meta-analysis of 29 research studies.Semantic proximity Read ↗

Methionine synthase A2756G polymorphism and cancer risk: a meta-analysis.Semantic proximity Read ↗

Role of polymorphism of methyltetrahydrofolate-homocysteine methyltransferase (MTR) A2756G and breast cancer risk.Semantic proximity Read ↗

Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.Semantic proximity Read ↗

Lack of association between methylenetetrahydrofolate reductase gene A1298C polymorphism and breast cancer susceptibility.Semantic proximity Read ↗

MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.Semantic proximity Read ↗

Association of 677 C>T (rs1801133) and 1298 A>C (rs1801131) polymorphisms in the MTHFR gene and breast cancer susceptibility: a meta-analysis based on 57 individual studies.Semantic proximity Read ↗

A meta-analysis of MTRR A66G polymorphism and colorectal cancer susceptibility.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.